LONDON, April 22 Britain's FTSE 100 index is seen
opening up by around 29 points, or 0.4 percent, on Tuesday with bid fever set to
boost pharmaceutical stocks, according to financial bookmakers. For more on the
factors affecting European stocks, please click on
* The UK blue chip index closed up by 0.6 percent, or 41.08 points, at
6,625.25 points on Thursday, marking a one-week closing high for the index.
* GLAXOSMITHKLINE :
Drugmaker GlaxoSmithKline said it was planning to buy Novartis'
global vaccines business for an initial cash consideration of $5.25 billion.
* ASTRAZENECA :
Pfizer Inc may come back to bid for British drug company AstraZeneca
Plc after its reported 60 billion pound ($101 billion) takeover approach was
rejected, since a deal could make sense for the U.S. pharmaceuticals giant as it
seeks to build up its cancer franchise.
* BARCLAYS :
Barclays is planning to withdraw from large parts of the metals,
agricultural and energy markets as part of a restructuring of its investment
bank, a person familiar with the matter said.
* UK CORPORATE DIARY:
DRAGON OIL TRADING UPDATE
TODAY'S UK PAPERS
> Financial Times
> Other business headlines
Multimedia versions of Reuters Top News are now available for:
* 3000 Xtra : visit topnews.session.rservices.com
* BridgeStation: view story .134
For more information on Top News visit
(Reporting by Sudip Kar-Gupta)